Electrofisiología Cardíaca Celular

Niessner, A; Tamargo, J; Koller, L; Saely, CH; Schmidt, TA; Savarese, G; Wassmann, S; Rosano, G; Ceconi, C; Torp-Pedersen, C; Kaski, JC; Kjeldsen, KP; Agewall, S; Walther, T; Drexel, H; Lewis, BS.

Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

EUROPEAN HEART JOURNAL. 2018; 39(24): 2274-2281 Nº de citas: 13 [doi:10.1093/eurheartj/ehx625]

Ponce-Balbuena, D; Guerrero-Serna, G; Valdivia, CR; Caballero, R; Diez-Guerra, FJ; Jimenez-Vazquez, EN; Ramirez, RJ; da Rocha, AM; Herron, TJ; Campbell, KF; Willis, BC; Alvarado, FJ; Zarzoso, M; Kaur, K; Perez-Hernandez, M; Matamoros, M; Valdivia, HH; Delpon, E; Jalife, J.

Cardiac Kir2.1 and Na(v)1.5 Channels Traffic Together to the Sarcolemma to Control Excitability

CIRCULATION RESEARCH. 2018; 122(11): 1501-1516 Nº de citas: 84 [doi:10.1161/CIRCRESAHA.117.311872]

Aboyans, V; Ricco, JB; Bartelink, MLEL; Bjorck, M; Brodmann, M; Cohnert, T; Collet, JP; Czerny, M; De Carlo, M; Debus, S; Espinola-Klein, C; Kahan, T; Kownator, S; Mazzolai, L; Naylor, AR; Roffi, M; Rother, J; Sprynger, M; Tendera, M; Tepe, G; Venermo, M; Vlachopoulos, C; Desormais, I; Widimsky, P; Kolh, P; Agewall, S; Bueno, H; Coca, A; De Borst, GJ; Delgado, V; Dick, F; Erol, C; Ferrini, M; Kakkos, S; Katus, HA; Knuuti, J; Lindholt, J; Mattle, H; Pieniazek, P; Piepoli, MF; Scheinert, D; Sievert, H; Simpson, I; Sulzenko, J; Tamargo, J; Tokgozoglu, L; Torbicki, A; Tsakountakis, N; Tunon, J; de Ceniga, MV; Windecker, S; Zamorano, JL.

Editor's Choice-2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2018; 55(3): 305-368 Nº de citas: 560 [doi:10.1016/j.ejvs.2017.07.018]

Subirana, I; Fito, M; Diaz, O; Vila, J; Frances, A; Delpon, E; Sanchis, J; Elosua, R; Munoz-Aguayo, D; Degano, IR; Marrugat, J.

Prediction of coronary disease incidence by biomarkers of inflammation, oxidation, and metabolism

Scientific Reports. 2018; 8: Nº de citas: 45 [doi:10.1038/s41598-018-21482-y]

Tamargo, J; Caballero, R; Delpon, E.

New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors

CARDIOVASCULAR DRUGS AND THERAPY. 2018; 32(1): 99-119 Nº de citas: 22 [doi:10.1007/s10557-017-6767-5]

Utrilla, RG; Nieto-Marin, P; Alfayate, S; Tinaquero, D; Matamoros, M; Perez-Hernandez, M; Sacristan, S; Ondo, L; de Andres, R; Diez-Guerra, FJ; Tamargo, J; Delpon, E; Caballero, R.

Kir2.1-Nav1.5 Channel Complexes Are Differently Regulated than Kir2.1 and Nav1.5 Channels Alone

Frontiers in Physiology. 2017; 8: Nº de citas: 37 [doi:10.3389/fphys.2017.00903]

Vonbank, A; Agewall, S; Kjeldsen, KP; Lewis, BS; Torp-Pedersen, C; Ceconi, C; Funck-Brentano, C; Kaski, JC; Niessner, A; Tamargo, J; Walther, T; Wassmann, S; Rosano, G; Schmidt, H; Saely, CH; Drexel, H.

Comprehensive efforts to increase adherence to statin therapy

EUROPEAN HEART JOURNAL. 2017; 38(32): 2473-112 Nº de citas: 54 [doi:10.1093/eurheartj/ehw628]

Tamargo, M; Tamargo, J.

Future drug discovery in renin-angiotensin-aldosterone system intervention

EXPERT OPINION ON DRUG DISCOVERY. 2017; 12(8): 827-848 Nº de citas: 27 [doi:10.1080/17460441.2017.1335301]

Tamargo, J; Rosano, G; Walther, T; Duarte, J; Niessner, A; Kaski, JC; Ceconi, C; Drexel, H; Kjeldsen, K; Savarese, G; Torp-Pedersen, C; Atar, D; Lewis, BS; Agewall, S.

Gender differences in the effects of cardiovascular drugs

European Heart Journal-Cardiovascular Pharmacotherapy. 2017; 3(3): 163-182 Nº de citas: 236 [doi:10.1093/ehjcvp/pvw042]

Niessner, A; Tamargo, J; Morais, J; Koller, L; Wassmann, S; Husted, SE; Torp-Pedersen, C; Kjeldsen, K; Lewis, BS; Drexel, H; Kaski, JC; Atar, D; Storey, RF; Lip, GYH; Verheugt, FWA; Agewall, S.

Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis

EUROPEAN HEART JOURNAL. 2017; 38(22): 1710-99 Nº de citas: 44 [doi:10.1093/eurheartj/ehv676]

Ruilope, LM; Tamargo, J.

Aldosterone a Relevant Factor in the Beginning and Evolution of Arterial Hypertension

AMERICAN JOURNAL OF HYPERTENSION. 2017; 30(5): 468-469 Nº de citas: 4 [doi:10.1093/ajh/hpx010]

Coll-Vinent, B; Martin, A; Sanchez, J; Tamargo, J; Suero, C; Malagon, F; Varona, M; Cancio, M; Sanchez, S; Carbajosa, J; Rios, J; Casanovas, G; Rafols, C; del Arco, C; EMERG-AF Investigators.

Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation)

STROKE. 2017; 48(5): 1344 Nº de citas: 24 [doi:10.1161/STROKEAHA.116.014855]

Tamargo, J; Rosano, GMC; Delpon, E; Ruilope, L; Lopez-Sendon, J.

Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes

INTERNATIONAL JOURNAL OF CARDIOLOGY. 2017; 233: 1-11 Nº de citas: 7 [doi:10.1016/j.ijcard.2016.11.124]

Ruilope, LM; Tamargo, J.

Renin-angiotensin system blockade: Finerenone

NEPHROLOGIE & THERAPEUTIQUE. 2017; 13: 47-53 Nº de citas: 14 [doi:10.1016/j.nephro.2017.02.003]

Caballero, R; Utrilla, RG; Amoros, I; Matamoros, M; Perez-Hernandez, M; Tinaquero, D; Alfayate, S; Nieto-Marin, P; Guerrero-Serna, G; Liu, QH; Ramos-Mondragon, R; Ponce-Balbuena, D; Herron, T; Campbell, KF; Filgueiras-Rama, D; Peinado, R; Lopez-Sendon, JL; Jalife, J; Delpon, E; Tamargo, J.

Tbx20 controls the expression of the KCNH2 gene and of hERG channels

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017; 114(3): 416-425 Nº de citas: 34 [doi:10.1073/pnas.1612383114]

Zamorano, JL; Lancellotti, P; Munoz, D; Aboyans, V; Asteggiano, R; Galderisi, M; Habib, G; Lenihan, DJ; Lip, GYH; Lyon, AR; Fernandez, TL; Mohty, D; Piepoli, MF; Tamargo, J; Torbicki, A; Suter, TM; Achenbach, S; Agewall, S; Badimon, L; Baron-Esquivias, G; Baumgartner, H; Bax, JJ; Bueno, H; Carerj, S; Dean, V; Erol, C; Fitzsimons, D; Gaemperli, O; Kirchhof, P; Kolh, P; Lancellotti, P; Nihoyannopoulos, P; Ponikowski, P; Roffi, M; Carneiro, AV; Windecker, S; Minotti, G; Cardinale, D; de Azambuja, E; Dent, S; Erol, C; Ewer, MS; Farmakis, D; Fietkau, R; Fitzsimons, D; McGale, P; Ringwald, J.

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

EUROPEAN JOURNAL OF HEART FAILURE. 2017; 19(1): 9-42 Nº de citas: 193 [doi:10.1002/ejhf.654]

Rivera-Torres, J; Calvo, CJ; Llach, A; Guzman-Martinez, G; Caballero, R; Gonzalez-Gomez, C; Jimenez-Borreguero, LJ; Guadix, JA; Osorio, FG; Lopez-Otin, C; Herraiz-Martinezd, A; Cabello, N; Vallmitjana, A; Benitez, R; Gordon, LB; Jalife, J; Perez-Pomares, JM; Tamargo, J; Delpon, E; Hove-Madsen, L; Filgueiras-Rama, D; Andres, V.

Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2016; 113(46): 7250-7259 Nº de citas: 46 [doi:10.1073/pnas.1603754113]

Tamargo, J; Ruilope, LM.

Investigational calcium channel blockers for the treatment of hypertension

EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2016; 25(11): 1295-1309 Nº de citas: 13 [doi:10.1080/13543784.2016.1241764]